
MLND
Healthcare · Biotechnology · $20.2M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2021
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 13, 2021 | After the close | -0.35 | -0.44 | -25.7% |
| Mar 29, 2021 | After the close | -0.34 | -0.39 | -13.6% |
| Nov 9, 2020 | After the close | -0.46 | -0.34 | +26.1% |
| Aug 10, 2020 | After the close | -0.55 | -0.56 | -2.4% |
| May 8, 2020 | After the close | -0.67 | -0.65 | +2.5% |
| Mar 11, 2020 | Before the open | -0.81 | -0.87 | -7.2% |
| Nov 13, 2019 | After the close | -0.83 | -0.87 | -5.3% |
| Aug 12, 2019 | Time not confirmed | -0.81 | -0.74 | +8.4% |
| May 15, 2019 | Time not confirmed | -0.70 | -0.78 | -10.9% |
| Mar 29, 2019 | Time not confirmed | -0.86 | -0.82 | +4.7% |
| Nov 9, 2018 | Time not confirmed | — | -2.38 | — |
| Aug 9, 2018 | Time not confirmed | — | -3.23 | — |
| May 3, 2018 | Time not confirmed | — | -3.09 |
As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.
| — |
| Mar 15, 2018 | Time not confirmed | -4.13 | -3.60 | +12.8% |